SS

Shawn Schiller

FT Forma Therapeutics: 3 patents #6 of 41Top 15%
VD Valo Early Discovery: 2 patents #12 of 30Top 40%
EC Eisai R&D Management Co.: 1 patents #24 of 101Top 25%
Overall (2021): #20,056 of 548,734Top 4%
6
Patents 2021

Issued Patents 2021

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
11130758 Tetrahydropyrazolopyrimidine compounds Roch Boivin, Eric Carlson, Atsushi Endo, Hans Hansen, Lynn Hawkins +4 more 2021-09-28
11111229 Tetrahydroquinoline compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +3 more 2021-09-07
11084831 Benzopiperazine compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +4 more 2021-08-10
10995078 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2021-05-04
10913753 Thienopyridine carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more 2021-02-09
10889592 Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors David Joseph Guerin, Kenneth W. Bair, Justin Andrew Caravella, Stephanos Ioannidis, David R. Lancia, Jr. +6 more 2021-01-12